12:00 AM
Mar 27, 2000
 |  BC Week In Review  |  Company News  |  Other News

Antex other research news

ANTX said that it has validated a zinc transporter protein from H. influenzae as a target to treat antibiotic resistant infections. The...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >